Replies to post #501231 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

My bad completely overlooked the date at the bottom..

Still “Scope: List of Outstanding Issues / Action: For adoption”, means there were issues - it would seem unlikely that they were not adopted.

[La Flaca]

Acknowledged but AVXL has/had the opportunity to respond by setting up a clarification meeting rather than via filing formal answers. We don’t know with 100 percent certainty that AVXL didn’t take that route.

As I’ve said before, Bristol Myers responded via clarification meeting and saved itself time and didn’t trigger clockstop2. But AVXL likely needs more time given its circumstances, type of disease, etc. My point is that it’s possible that a clockstop 2 isn’t triggered even with the list of questions published with “adoption” language shown in a plenary meeting’s highlights. That’s exactly the way it happened for Onureg.